{"id":"tp-52946","type":"article-newspaper","title":"Foghorn Therapeutics Posts $0.80 Q3 GAAP EPS, $83.5 Million Revenue","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/52946","datePublished":"2026-11-10T09:05:31.000Z","dateModified":"2026-11-10T09:05:31.000Z","language":"en","abstract":"Research and development expenses fell $1.2 million from a year earlier.","section":"Business","references":[]}